Background Sarcopenia, an age-related decline in muscle mass and function, is one of the
most important health problems in elderly with a high rate of adverse outcomes. However …

The original definition of sarcopenia refers to the age‐related loss of muscle mass. The
literature suggests that the prevalence of sarcopenia in 60‐to 70‐year‐olds is in the range of …

Introduction A muscle mass normalized for height 2 (MMI) or for body weight (SMI) below
2SD under the mean for a young population defines sarcopenia. This study aimed at setting …

Background. Sarcopenia is associated with increased risk of adverse outcomes in older
people. Aim of the study was to explore the predictive value of the European Working Group …

Background Sarcopenia, defined as low muscle mass (LMM), and dynapenia have been
associated with adverse outcomes in elderly. Objective Contrast the association of …

Methods The aim of this paper is to define terms commonly related to sarcopenia to enable
standardization of these terms in research and clinical settings. The Global Leadership …

Background Operational definitions of sarcopenia, ie loss of muscle function and mass, have
been proposed by the European Working Group on Sarcopenia in Older People (EWGSOP) …

Abstract Background in 2010, the European Working Group on Sarcopenia in Older People
(EWGSOP) published a sarcopenia definition that aimed to foster advances in identifying …

The aim of this review is to describe the epidemiology of sarcopenia, specifically prevalence,
health outcomes, and factors across the life course that have been linked to its development …

Introduction: In the definition of the European Working Group on Sarcopenia in Older People
(EWGSOP), different cut-off limits are proposed for appendicular lean mass, muscle strength …